Michael B. Mason - 01 Feb 2023 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP & Pres., Lilly Diabetes
Signature
/s/ Jonathan Groff for Michael B. Mason, pursuant to attached authorization
Issuer symbol
LLY
Transactions as of
01 Feb 2023
Transactions value $
-$1,010,080
Form type
4
Filing time
03 Feb 2023, 15:51:56 UTC
Previous filing
11 Feb 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Options Exercise $0 +6.69K +24.32% $0.00 34.2K 01 Feb 2023 Direct
transaction LLY Common Stock Tax liability -$1.01M -2.94K -8.58% $344.15 31.3K 01 Feb 2023 Direct
holding LLY Common Stock 957 01 Feb 2023 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Options Exercise $0 -6.69K -100% $0.00* 0 01 Feb 2023 Common Stock 6.69K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Remarks:

Exhibit 24 - Power of Attorney